NCT06764485 2026-01-28
rechARge
Celgene
Phase 3 Recruiting
Clinical Trials
3 trialsNCT03437941 2023-05-06
Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With mCRPC
Corcept Therapeutics
Phase 1/2 Completed
NCT03478904 2021-05-10
Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated